Provider: View Press Release
Type: Link
Title: Press Release: Sanofi announces changes to its Executive Committee
Description: Sanofi announces changes to its Executive Committee Paris, August 31st, 2023. Sanofi announces the following changes to its Executive Committee: Houman...
Provider: View Press Release
Type: Link
Title: Media Update: New data at ERS showcases Sanofi's scientific leadership in addressing unmet needs across a variety of respiratory conditions
Description: New data at ERS showcases Sanofi's scientific leadership in addressing unmet needs across a variety of respiratory conditions Data presentations...
Provider: View Press Release
Type: Link
Title: Media Update: New data at ERS showed Xenpozyme® (olipudase alfa) improved respiratory functions in adults with ASMD
Description: New data at ERS showed Xenpozyme® (olipudase alfa) improved respiratory functions in adults with ASMD Paris, September 14, 2023. New data presented in...
Provider: View Press Release
Type: Link
Title: Press Release: Sanofi supporting vulnerable communities as part of commitment to social impact and fight against climate change
Description: Sanofi supporting vulnerable communities as part of commitment to social impact and fight against climate change Paris, September 19, 2023 – As...
Provider: View Press Release
Type: Link
Title: Press Release: Availability of the Q3 2023 Memorandum for modelling purposes
Description: Availability of the Q3 2023 Memorandum for modelling purposes Paris, France – September 22, 2023. Sanofi announced today that its Q3 2023 Memorandum...
Provider: View Press Release
Type: Link
Title: Press Release: Once-weekly ALTUVIIIO® approved in Japan as a new class of factor VIII therapy for hemophilia A
Description: Once-weekly ALTUVIIIO® approved in Japan as a new class of factor VIII therapy for hemophilia A ALTUVIIIO is a first-in-class,...